Infectious and Tropical Diseases Research Center, Health Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Department of Microbiology, Faculty of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Mol Biol Rep. 2022 Jul;49(7):6135-6143. doi: 10.1007/s11033-022-07404-2. Epub 2022 Apr 2.
The global rise in drug-resistant Mycobacterium tuberculosis (M.tb), and especially the significant prevalence of isoniazid (INH)-resistance constitute a significant challenge to global health. Therefore, the present study aimed to investigate mutations in prevalent gene loci-involved in INH-resistance phenotype-among M.tb clinical isolates from southwestern Iran.
Drug susceptibility testing (DST) was performed using the conventional proportional method on confirmed 6620 M.tb clinical isolates, and in total, 15 INH-resistant and 18 INH-susceptible isolates were included in the study. Fragments of six genetic loci most related to INH-resistance (katG, inhA promoter, furA, kasA, ndh, oxyR-ahpC intergenic region) were PCR-amplified and sequenced. Mutations were explored by pairwise alignment with the M.tb H37Rv genome.
The analysis of gene loci revealed 13 distinct mutations in INH-resistant isolates. 60% (n = 9) of the INH-resistant isolates had mutations in katG, with codon 315 predominately (53.3%, n = 8). Mutation at InhA - 15 was found in 20% (n = 3) of resistant isolates. 26.7% (n = 4) of the INH-resistant isolates had kasA mutations, of which G269S substitution was the most common (20%, n = 3). The percentage of mutations in furA, oxyR-ahpC and ndh was 6.7% (n = 1), 46.7% (n = 7), and 20% (n = 3), respectively. Of the mutations detected in ndh and oxyR-ahpC, 5 were also observed in INH-susceptible isolates. This study revealed seven novel mutations, four of which were exclusively in resistant isolates.
This study supports the usefulness of katG and inhA mutations as a predictive molecular marker for INH resistance. Co-detection of katG S315 and inhA-15 mutations identified 73.3% (11 out of 15 isolates) of INH-resistant isolates.
全球耐多药结核分枝杆菌(M.tb)的上升,尤其是异烟肼(INH)耐药率的显著流行,对全球健康构成了重大挑战。因此,本研究旨在调查来自伊朗西南部的 M.tb 临床分离株中与 INH 耐药表型相关的流行基因座的突变。
对确诊的 6620 株 M.tb 临床分离株进行药物敏感性试验(DST),采用常规比例法,共纳入 15 株 INH 耐药株和 18 株 INH 敏感株进行研究。PCR 扩增并测序与 INH 耐药相关的六个基因座的六个遗传片段(katG、inhA 启动子、furA、kasA、ndh、oxyR-ahpC 基因间区)。通过与 M.tb H37Rv 基因组的两两比对来探讨突变。
基因座分析显示 INH 耐药株中有 13 个不同的突变。60%(n=9)的 INH 耐药株在 katG 中发生突变,主要是密码子 315(53.3%,n=8)。inhA-15 的突变在 20%(n=3)的耐药株中发现。26.7%(n=4)的 INH 耐药株有 kasA 突变,其中 G269S 取代最常见(20%,n=3)。furA、oxyR-ahpC 和 ndh 的突变率分别为 6.7%(n=1)、46.7%(n=7)和 20%(n=3)。在检测到的 ndh 和 oxyR-ahpC 突变中,有 5 个也在 INH 敏感株中发现。本研究共发现 7 个新突变,其中 4 个仅存在于耐药株中。
本研究支持 katG 和 inhA 突变作为 INH 耐药的预测分子标志物的有用性。katG S315 和 inhA-15 突变的共检测可鉴定 73.3%(15 株中的 11 株)的 INH 耐药株。